Neuroimaging features of neurodegeneration with brain iron accumulation

American Journal of Neuroradiology

Volumn 33, Issue 3, 2012, Pages 407-414

  Kruer, Michael C ^a,e   Boddaert, N ^f   Schneider, A ^g   Houlden, H ^h   Bhatia, K P ⁱ   Gregory, A ^b   Anderson, J C ^c   Rooney, W D ^b,c,d   Hogarth, P ^b,c   Hayflick, S J ^b,e  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Oregon Health and Science University Department of Biomedical Engineering   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g UNIVERSITY OF LÜBECK   (Germany)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CERULOPLASMIN; FERRITIN; PANTOTHENATE KINASE 2; PHOSPHOLIPASE;

AUTOSOMAL DOMINANT DISORDER; FOCAL DYSTONIA; GAIT DISORDER; GENE MUTATION; GENETIC SCREENING; GLOBUS PALLIDUS; HUMAN; HUNTINGTON DISEASE LIKE SYNDROME; HYPERFERRITINEMIA; LOSS OF FUNCTION MUTATION; NEUROAXONAL DYSTROPHY; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; PARKINSONISM; REVIEW;

ALGORITHMS; BRAIN; BRAIN DISEASES, METABOLIC; HUMANS; IMAGE ENHANCEMENT; IRON OVERLOAD; NEURODEGENERATIVE DISEASES; NEUROIMAGING;

EID: 84863337915     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2677     Document Type: Review

References (40)

1. McNeill A, Birchall D, Hayflick SJ, et al. T2*and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008;29;70:1614-19 (Pubitemid 351620317)
2. Yilmaz A, Budak H, Longo R. Paramagnetic contribution of serum iron to the spin-lattice relaxation rate (1//'1) determined by MRI. Appl Magn Reson 1998;14:51-58
3. Burgetova A, Seidl Z, Krasensky J, et al. Multiple sclerosis and the accumulation of iron in the basal ganglia: quantitative assessment of brain iron using MRI t(2) relaxometry. Eur Neurol 2010;63:136-43
4. Miszkiel KA, Paley MN, Wilkinson ID, et al. The measurement of R2, R2*and R2′ in HIV-infected patients using the prime sequence as a measure of brain iron deposition. Magn Reson Imaging 1997;15:1113-19 (Pubitemid 27516460)
5. Waldvogel D, van Gelderen P, Hallett M. Increased iron in the dentate nucleus of patients with Friedrich's ataxia. Ann Neurol 1999;46:123-25 (Pubitemid 29314392)
6. Brar S, Henderson D, Schenck J, et al. Iron accumulation in the substantia nigra of patients with Alzheimer disease and parkinsonism. Arch Neurol 2009;66:371-74
7. Gerlach M, Ben-Shachar D, Riederer P, et al. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 1994;63:793-807 (Pubitemid 24266591)
8. Kobari M, Nogawa S, Sugimoto Y, et al. Familial idiopathic brain calcification with autosomal dominant inheritance. Neurology 1997;48:645-49 (Pubitemid 27120100)
9. Storey P, Thompson AA, Carqueville CL, et al. R2*imaging of transfusional iron burden at 3T and comparison with 1.5T. J Magn Reson Imaging 2007;25: 540-47 (Pubitemid 46355416)
10. Hallgren B, Sourander P. The Effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3:41-51
11. Aquino D, Bizzi A, Grisoli M, et al. Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 2009;252:165-72
12. Boddaert N, Le Quan Sang KH, Rötig A, et al. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 2007;110:401-08 (Pubitemid 47026862)
13. Hayflick SJ, Penzien JM, Michl W, et al. Cranial MRI changes may precede symptoms in Hallervorden-Spatz syndrome. Pediatr Neurol 2001;25:166-69
14. Gregory A, Westaway SK, Holm IE, et al. Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology 2008;71:1402-09
15. Forni GL, Balocco M, Cremonesi L, et al. Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation. Mov Disord 2008;23:904-07
16. Zhou B, Westaway SK, Levinson B, et al. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001;28: 345-49 (Pubitemid 32702423)
17. Freeman K, Gregory A, Turner A, et al. Intellectual and adaptive behaviour functioning in pantothenate kinase-associated neurodegeneration. J Intellect Disabil Res 2007;51(pt 6):417-26 (Pubitemid 46746070)
18. Kumar N, Boes CJ, Babovic-Vuksanovic D, et al. The "eye-of-the- tiger" sign is not pathognomonic of the PANK2 mutation. Arch Neurol 2006;63:292-93 (Pubitemid 43261746)
19. Kruer MC, Hiken M, Gregory A, et al. Novel histopathologic findings in molecularly- confirmed pantothenate kinase-associated neurodegeneration. Brain 2011;134(pt 4):947-58
20. Hayflick SJ, Hartman M, Coryell J, et al. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. AJNR Am J Neuroradiol 2006;27:1230-33 (Pubitemid 44897631)
21. Baumeister FA, Auer DP, Hörtnagel K, et al. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome. Neuropediatrics 2005;36:221-22 (Pubitemid 41117122)
22. Strecker K, Hesse S, Wegner F, et al. Eye of the tiger sign in multiple system atrophy. Eur J Neurol 2007;14:e1-2 (Pubitemid 47621939)
23. Molinuevo JL, Muñoz E, Valldeoriola F, et al. The eye of the tiger sign in cortical- basal ganglionic degeneration. Mov Disord 1999;14:169-71 (Pubitemid 29224699)
24. Morgan NV, Westaway SK, Morton JE, et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 2006;38:752-54 (Pubitemid 43980594)
25. Wild EJ, Mudanohwo EE, Sweeney MG, et al. Huntington's disease phenocopies are clinically and genetically heterogeneous. Mov Disord 2008;23:716-20
26. Chinnery PF, Crompton DE, Birchall D, et al. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain 2007;130(pt 1):110 -19. Epub 2006 Dec 2
27. di Patti MC, Maio N, Rizzo G, et al. Dominant mutants of ceruloplasmin impair the copper loading machinery in aceruloplasminemia. J Biol Chem 2009;284:4545-54. Epub 2008 Dec 18
28. Merle U, Tuma S, Herrmann T, et al. Evidence for a critical role of ceruloplasmin oxidase activity in iron metabolism of Wilson disease gene knockout mice. J Gastroenterol Hepatol 2010;25:1144-50
29. Kruer MC, Paisán-Ruiz C, Boddaert N, et al. Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol 2010;68:611-18.
30. Schneider SA, Paisan-Ruiz C, Quinn NP, et al. ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Mov Disord 2010;25: 979-84
31. Behrens MI, Brüggemann N, Chana P, et al. Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations. Mov Disord 2010;25:1929-37
32. Alazami AM, Al-Saif A, Al-Semari A, et al. Mutations in C2orf37, encoding a nucleolar protein, cause hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome. Am J Hum Genet 2008;83:684-91
33. Kuo YM, Hayflick SJ, Gitschier J. Deprivation of pantothenic acid elicits a movement disorder and azoospermia in a mouse model of pantothenate kinase-associated neurodegeneration. J Inherit Metab Dis 2007;30:310-17 (Pubitemid 46881677)
34. Kruer MC, Gregory A, Hogarth P, et al. Childhood static encephalopathy and cerebral palsy followed by abrupt-onset progressive neurodegeneration in adulthood: a novel neurodegeneration with brain iron accumulation (NBIA) phenotype. Poster presentations, American Academy of Cerebral Palsy and Developmental Medicine 63rd Annual Meeting, Scottsdale, AZ, September 2009.
35. Hayflick SJ. Dystonia-parkinsonism disease gene discovery: expect surprises. Ann Neurol 2009;65:2-3
36. Paisan-Ruiz C, Bhatia KP, Li A, et al. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol 2009;65:19-23
37. Kurian MA, Morgan NV, MacPherson L, et al. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology 2008;70:1623-29 (Pubitemid 351620319)
38. Paisán-Ruiz C, Li A, Schneider SA, et al. Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging 2010;33:814-23
39. Galvin JE, Giasson B, Hurtig HI, et al. Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology. Am J Pathol 2000;157:361-68 (Pubitemid 30626903)
40. Wakabayashi K, Fukushima T, Koide R, et al. Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and Lewy body pathology. Acta Neuropathol 2000;99:331-36 (Pubitemid 30099186)